Martin Shkreli can’t work in pharmaceuticals again, appeals court rules
The U.S. Court of Appeals for the 2nd Circuit on Tuesday upheld a lifetime ban against “Pharma Bro” Martin Shkreli to work in pharmaceuticals. The ban came after he hiked the price of Daraprim, which treats a parasitic disease that strikes those with pregnancy, cancer and AIDS, from $17.50 to $750 a pill in 2015. […]